A recent U.S. federal court ruling in Thomson Reuters Enterprise Centre GmbH v. Ross Intelligence Inc. determined that ...

A US judge has ruled in favor of Thomson Reuters in a AI training fight against Ross Intelligence, a legal AI startup, ...

The artificial intelligence revolution brought big advances to the tech industry. However, it also brought serious challenges ...

HOW ‘FAIR USE’ WORKS. The fair use doctrine exists to safeguard freedom of expression and to create an environment that ...

The case, filed in 2020, accused Ross Intelligence of reproducing materials from Thomson Reuters' Westlaw legal research ...

The copyright lawsuit was filed after Ross Intelligence used Thomson Reuters’ Westlaw database to train its AI-powered legal ...

A judge looked at possible copyright infringement defenses for Ross Intelligence and said, ‘I reject them all.’ ...

In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, and (ii) the final terms of the dual proposal to the 2025 OCEANEs holders announced on ...

Alnylam awaits FDA decisions on Amvuttra & Fitusiran next month, poised to boost revenue, profitability, and share growth.

An offensive by M23 fighters is disrupting health services and displacing people in a region already beset by health ...

Nearly 4,000 people have signed an open letter calling on Christie’s New York to cancel an upcoming sale dedicated solely to ...

Q4 2024 Earnings Call Transcript February 11, 2025 Royalty Pharma plc misses on earnings expectations. Reported EPS is ...